Resveratrol engages selective apoptotic signals in gastric adenocarcinoma cells

William L Riles1, Jason Erickson, Sanjay Nayyar

  • 1Division of Gastroenterology, John H. Stroger Hospital of Cook County, 1901 W. Harrison Street Chicago, IL 60612, USA.

Abstract

Insights

Resveratrol induces apoptosis in gastric cancer cells by activating intracellular signals, independent of mitochondrial changes. The specific apoptotic pathways activated by resveratrol vary between cell types, suggesting a role for cell differentiation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Gastric adenocarcinoma is a significant global health concern.
  • Resveratrol, a natural polyphenol, exhibits anti-cancer properties.
  • Understanding resveratrol's mechanism of action in gastric cancer is crucial for therapeutic development.

Purpose of the Study:

  • To investigate the intracellular apoptotic pathways activated by resveratrol in gastric adenocarcinoma cell lines.
  • To determine if p53 status influences resveratrol-induced apoptosis.
  • To elucidate the cell-type-specific responses to resveratrol.

Main Methods:

  • Quantification of apoptotic cells via nuclear fragmentation.
  • Measurement of caspase activity using photometric detection.
  • Assessment of cytochrome C activity and protein expression via Western blot analysis.

Main Results:

  • Resveratrol induced DNA fragmentation and cleavage of nuclear lamins and PARP in gastric cancer cells, regardless of p53 status.
  • Apoptosis was not mediated by mitochondrial outer membrane permeabilization or changes in Bcl-2 family proteins.
  • Resveratrol modulated p53, survivin, caspase 3, and cytochrome C oxidase activities in a cell-type-dependent manner.

Conclusions:

  • Resveratrol-induced apoptosis in gastric cancer is mediated by cell-type-specific intracellular signaling pathways.
  • These observed differences in apoptotic signaling may be linked to the differentiation status of the gastric cancer cells.
  • Resveratrol's efficacy may be influenced by the specific molecular characteristics of the tumor.